Pharma Foods International Co., Ltd. (TSE: 2929)
Health Care · Biotechnology · JP
¥608.00
-0.65% today · -40.6% 1Y
Pharma Foods International Co., Ltd. (TSE: 2929) operates in the Biotechnology industry within the Health Care sector. The company is valued at $111.08M and employs 613 people.
Over the last twelve months the share price has lost 40.6%, trading between 513.00 and 1.06K.
Tweenvest scores Pharma Foods International Co., Ltd. across four factors: quality 64/100, value 51/100, growth 62/100, dividend 66/100. Its strongest factor is dividend.
2929 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $111.08M
- Revenue (TTM)
- $427.46M
- P/E
- 40.92
- EPS
- 14.86
- Dividend yield
- 4.11%
- Beta (5Y)
- 0.32
- 52-week high
- ¥1,064.00
- 52-week low
- ¥513.00
- Avg volume (3M)
- —
- Shares outstanding
- 29.04M
- Employees
- 613
- Next earnings
- —
About Pharma Foods International Co., Ltd.
Pharma Foods International Co., Ltd. is a Japanese enterprise dedicated to the research, development, and commercialization of ingredients for functional foods. Its diverse product portfolio features items such as Pharma-GABA, Bonepep, Ovopron (a specific egg yolk globulin), Delicious Catechin, RunPep, and enriched Folic Acid Egg. Additionally, the company offers iHA, a compound recognized for stimulating the body's hyaluronic acid production. Furthermore, Pharma Foods International Co., Ltd. has entered into a licensing arrangement with Mitsubishi Tanabe Pharma Corporation for a novel therapeutic antibody designed to combat autoimmune conditions. The firm was founded in 1997 and maintains its corporate headquarters in Kyoto, Japan.
- ISIN
- JP3802310007
- Founded
- 1997
- Listed since
- Jun 12, 2006
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $467.44B | $264.52 | -0.17% |
| Amgen Inc.NasdaqGS: AMGN | $239.95B | $443.84 | +1.03% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.95B | $146.74 | +0.42% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.79B | $547.59 | -0.08% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $82.73B | $828.50 | -0.66% |
| argenx SEENXTBR: ARGX | $63.06B | €874.20 | +1.16% |
| CSL LimitedASX: CSL | $57.94B | AU$169.11 | +0.48% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $141.77 | +2.07% |
Figures last refreshed Aug 18, 2026.